Article Details
Retrieved on: 2022-11-24 21:46:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Atlas Venture Fund X, L.P., the 10% Owner of Kymera Therapeutics Inc., sale 21,085 shares at $30.00 during a trade that took place back on Nov 03, ...
Article found on: newsheater.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here